Evidence map›Paper›PMID 34050628›Full record

Trial reportZoonoses and public health2021

Prevention of Lyme and other tickborne diseases using a rodent-targeted approach: A randomized controlled trial in Connecticut.

Alison F Hinckley, Sara A Niesobecki, Neeta P Connally, Sarah A Hook, Brad J Biggerstaff, Kalanthe A Horiuchi, Andrias Hojgaard, Paul S Mead, James I Meek

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Zoonoses and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Why are the ticks winning, and what can we do about it?Ticks and tick-borne diseases · 2026
    Review
  3. Review
  4. Article
  5. Minor Hosts Have a Major Impact on the Enzootic Transmission of Borrelia burgdorferi.The American journal of tropical medicine and hygiene · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Does Experimental Reduction of Blacklegged Tick (Pathogens (Basel, Switzerland) · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Tick species infesting humans in the United States.Ticks and tick-borne diseases · 2022
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Alison F HinckleyDivision of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA.ORCID 0000-0003-2853-5165
Sara A NiesobeckiConnecticut Emerging Infections Program, Yale School of Public Health, New Haven, CT, USA.
Neeta P ConnallyDepartment of Biological & Environmental Sciences, Western Connecticut State University, Danbury, CT, USA.
Sarah A HookDivision of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA.ORCID 0000-0002-4981-1053
Brad J BiggerstaffDivision of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA.
Kalanthe A HoriuchiDivision of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA.
Andrias HojgaardDivision of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA.
Paul S MeadDivision of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA.
James I MeekConnecticut Emerging Infections Program, Yale School of Public Health, New Haven, CT, USA.
Centers for Disease Control and Prevention · USWestern Connecticut State University · US

Funding

Epidemiology and Laboratory Capacity for Infectious Diseases SurveillanceU50CI000488 · CI · ARKANSAS STATE DEPARTMENT OF HEALTH · PI REEVE, GORDON R. · 2007 to 2011
$3.6M
Intramural CDC HHS CC999999NCEZID CDC HHS U50 CK000195NCPDCID CDC HHS U50 CI000488
6 · The paper itself

Abstract

Tickborne diseases are an increasing public health problem in the northeastern USA. Bait boxes that apply acaricide to rodents have been shown in small field studies to significantly reduce abundance of Ixodes scapularis ticks as well as their pathogen infection rates in treated areas. The effectiveness of this intervention for preventing human tickborne diseases (TBDs) has not been demonstrated. During 2012-2016, TickNET collaborators conducted a randomized, blinded, placebo-controlled trial among 622 Connecticut households. Each household received active (containing fipronil wick) or placebo (empty) bait boxes in their yards over two consecutive years. Information on tick encounters and TBDs among household members was collected through biannual surveys. Nymphal ticks were collected from a subset of 100 properties during spring at baseline, during treatment, and in the year post-intervention. Demographic and property characteristics did not differ between treatment groups. There were no significant differences post-intervention between treatment groups with respect to tick density or pathogen infection rates, nor for tick encounters or TBDs among household members. We found no evidence that rodent-targeted bait boxes disrupt pathogen transmission cycles or significantly reduce household risk of tick exposure or TBDs. The effectiveness of this intervention may depend on scale of use or local enzootic cycles.

Indexed as

AnimalsAntiparasitic AgentsConnecticutHumansIxodesLyme DiseasePyrazolesRodentiaTick InfestationsAntiparasitic AgentsfipronilPyrazolesbait boxeshumanspesticidepreventionrodentstickborne diseasesticks

Identifiers

PMID34050628
PMCPMC10898493
OpenAlexW3164821215

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.